Placebo-Controlled Randomized Trial of Adjuvant Imatinib Mesylate Following the Resection of Localized, Primary Gastrointestinal Stromal Tumor (GIST)
      QxMD      Google Scholar   
Citation:
Lancet vol 373 (9669) 1097-1104
Year:
2009
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
Yes
Book Volume:
Parents:
452  
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
CA102613, R21 CA094503-02, R01 CA102613, R01 CA102613-05, U10 CA076001, CA94503, R21 CA094503  
Corr. Author:
 
Authors:
                               
Networks:
 
Study
ACOSOG-Z9001
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
Article